Goldline Pharmaceutical Ltd. IPO
listed · BSE SME · Bookbuilding IPO
Goldline Pharmaceutical Ltd. IPO was a book-built issue on BSE SME with a price band of ₹41–₹43 per share, open for bidding from 12 May 2026 to 14 May 2026.
Last updated: · How we collect data
IPO overview
The issue was a book-built issue, made up entirely of new shares, so the proceeds go to the company.
Bids were accepted within a price band of ₹41–₹43 per share (face value ₹10); the final issue price is set within this band after bidding closes.
Applications were made in lots of 3,000 shares, so one lot costs ₹1,29,000 at the upper end of the price band.
The shares listed on BSE SME on 19 May 2026.
Cumulative Capital Pvt.Ltd. was the book-running lead manager.
Promoters held 79.70% of the company before the issue.
- Issue type
- Bookbuilding IPO
- Issue structure
- Fresh capital only
- Price
- ₹41–₹43 per share
- Lot size
- 3,000 shares
- Minimum investment (1 lot)
- ₹1,29,000
- Face value
- ₹10 per share
- Exchange
- BSE SME
- Lead manager
- Cumulative Capital Pvt.Ltd.
IPO timeline
- Bidding opens 12 May 2026
- Bidding closes 14 May 2026
- Basis of allotment —
- Refunds / unblocking —
- Shares credited to demat —
- Listing 19 May 2026
Bidding ran from 12 May 2026 to 14 May 2026.
The shares listed on 19 May 2026.
Sources and data methodology
NSE & BSE public-issue data; Chittorgarh and InvestorGain (fill gaps only). Methodology · Report an error
Tools
IPOs around the same time
- Recode Studios Ltd. · opened 5 May 2026
- Harikanta Overseas Ltd. · opened 20 May 2026
- Vegorama Punjabi Angithi Ltd. · opened 20 May 2026
- Autofurnish Ltd. · opened 21 May 2026
- M R Maniveni Foods Ltd. · opened 22 May 2026